Sarissa Capital Management as of June 30, 2016
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 15 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 26.9 | $95M | 13M | 7.39 | |
| Biogen Idec (BIIB) | 21.3 | $75M | 310k | 241.82 | |
| Medicines Company | 16.7 | $59M | 1.8M | 33.63 | |
| Intra Cellular Therapies (ITCI) | 7.4 | $26M | 675k | 38.82 | |
| Pacira Pharmaceuticals (PCRX) | 6.2 | $22M | 653k | 33.73 | |
| Raptor Pharmaceutical | 4.4 | $15M | 2.9M | 5.37 | |
| Array BioPharma | 4.3 | $15M | 4.3M | 3.56 | |
| Quest Diagnostics Incorporated (DGX) | 3.7 | $13M | 159k | 81.41 | |
| Perrigo Company (PRGO) | 2.6 | $9.1M | 100k | 90.67 | |
| Apricus Bioscience | 1.6 | $5.8M | 15M | 0.40 | |
| Advaxis | 1.4 | $4.9M | 600k | 8.09 | |
| Aegerion Pharmaceuticals | 1.1 | $3.9M | 2.6M | 1.49 | |
| Abbvie (ABBV) | 0.9 | $3.1M | 50k | 61.90 | |
| Vivus | 0.8 | $2.9M | 2.6M | 1.12 | |
| AVEO Pharmaceuticals | 0.5 | $1.9M | 2.0M | 0.96 |
